What are the symptoms of mid-term brain metastasis of nasopharyngeal carcinoma and what to do

Like many other cancer diseases, nasopharyngeal carcinoma often metastasizes. Here are some symptoms of mid-stage brain metastasis of nasopharyngeal carcinoma and what to do?

Nasopharyngeal carcinoma is a malignant tumor originating from the epithelium covering the nasopharyngeal mucosa. It is one of the most common malignant tumors in my country, with a high frequency of malignant transformation and an average natural survival time of 18.7 months. The onset is hidden and it is difficult to be detected in the early stage. The causes of nasopharyngeal carcinoma include Epstein-Barr virus infection, genetic factors, and some unhygienic diets.

Nasopharyngeal carcinoma metastases to the brain and manifests clinical symptoms such as fatigue, hemiplegia, hemiphasia, aphasia, ataxia, nystagmus, etc. Metastatic tumors located in the sellar region manifest as polydipsia and polyuria. Increased intracranial pressure is a typical manifestation of brain metastasis in patients. Due to the rapid growth of the tumor and severe edema around it, the symptoms of increased intracranial pressure are more obvious. Patients will experience a series of symptoms such as headache, malignant vomiting, and drowsiness. CT shows isodense, low-density or high-density shadows, with obvious surrounding edema bands. Sometimes low-density metastatic lesions are covered by edema bands and are not easy to detect.

During enhanced scanning, metastatic lesions are ring-shaped or uniformly enhanced. Enhanced brain MRI scans can help distinguish radiation-induced brain damage from brain metastatic lesions. There are reports that patients with nasopharyngeal carcinoma may have single metastatic lesions in the cerebellopontine angle, and MRI can sensitively detect metastasis in this rare location.

For nasopharyngeal carcinoma brain metastasis, timely surgical treatment is recommended, which can effectively prevent the spread of cancer cells, but the use of appropriate treatment techniques after surgery is a better treatment method. Currently, postoperative combined biological immunotherapy technology is of great help for future care. It can help patients improve their own immune capabilities and effectively prevent the metastasis and recurrence of cancer cells. It is the preferred treatment for patients with nasopharyngeal carcinoma brain metastasis.